- Testing individuals with epilepsy via a targeted panel of genes with therapeutic associations may expedite diagnosis and tailor management
- Over 70% of epilepsy mutations in our cohort were found in genes with therapeutic associations
- Starting with a targeted panel of management-associated genes may maximize diagnostic yield and minimize potential for results of uncertain significance